MK-2060 is a humanized monoclonal antibody inhibitor targeting FXI. It is applicable for research in atherosclerotic thrombosis and venous thromboembolism.
CAS Number:
[2812480-88-7]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
